Radioprotectant Activity of 5‐Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice
Author(s) -
John A. Kuykendall,
H. E. Simmons,
Henry J. Irving,
Mark A. Wear,
Paul Sorenson,
Linda G. Tipton,
Kenchasha M. Maddox,
Elsie L. Williams,
Van Anh Pham-Tran,
Chassie Credit,
Israt L. Chowdhury,
Shaheen Khan,
J. Brooks Tipton,
William M. Willingham,
John R. J. Sorenson
Publication year - 1999
Publication title -
metal-based drugs
Language(s) - English
Resource type - Journals
ISSN - 0793-0291
DOI - 10.1155/mbd.1999.135
Subject(s) - irradiation , medicine , radiochemistry , chemistry , physics , nuclear physics
Survival and changes in mean body mass of whole-body irradiated mice were determined to examine the radioprotectant activity of 5-diethylsulfonamoylsalicylatocopper(II) [Cu(II) (5-DESS)]. One of four groups of 25 female C57BL/6 mice were treated subcutaneously (sc)with 0, 10, 20, 40, 60, 80, 100, or 120 mumol Cu(II)(5- DESS)/kg of body mass 3 hours before exposure to 8.0 Gy, gamma irradiation. In this paradigm, doses of Cu(II)(5- DESS) increased survival up to 92% above vehicle-treated control mice (P = 0.008). Mean body mass determinations revealed that mice treated with 80 to 120 mumol Cu(II)(5-DESS)/kg of body mass exhibited a smaller decrease in body mass than other complex-treated groups. These results support the hypothesis that Cu(II)(5-DESS) is an effective radioprotectant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom